Table 3 Comorbidities in patients in surviving vs dying within the first 3 months after start of RRT
% in those who Survived | % in those who died | Risk estimate (95 % CI) | ||
|---|---|---|---|---|
Age | <75 | 48.0 | 27.5 | 1.41 |
75–80 | 17.4 | 16.7 | (1.30–1.56) | |
80–85 | 18.6 | 26.4 | ||
85–90 | 11.7 | 20.3 | ||
>90 | 4.3 | 9.1 | ||
Gender | male | 56.6 | 57.6 | 0.96 |
female | 43.4 | 42.4 | (0.75–1.23) | |
Heart Failure | Stage 0 | 52.0 | 31.1 | 1.61 |
Stage 1 | 14.3 | 11.2 | (1.45–1.80) | |
Stage 2 | 16.5 | 13.8 | ||
Stage 3 | 14.0 | 23.5 | ||
Stage 4 | 3.3 | 20.4 | ||
Angina Pectoris | None | 77.7 | 58.7 | 1.54 |
Grade 1 | 10.4 | 14.8 | (1.35–1.73) | |
Grade 2 | 6.4 | 7.1 | ||
Grade 3 | 4.1 | 13.8 | ||
Grade 4 | 1.5 | 5.6 | ||
Peripheral Vascular Disease | None | 80.5 | 68.4 | 1.26 |
Claudication | 10.9 | 18.4 | (1.08–1.47) | |
Resting ischemia | 2.4 | 5.6 | ||
Necrosis/amputation | 6.2 | 7.7 | ||
COPD | None | 78.0 | 57.7 | 1.61 |
Mild | 12.6 | 24.5 | (1.37–1.88) | |
Moderate | 7.2 | 10.7 | ||
Severe | 2.3 | 7.1 | ||
Myocardial Infarction | NO | 82.5 | 74.0 | 1.66 |
YES | 17.5 | 26.0 | (1.19–2.3) | |
PCI | NO | 82.3 | 81.6 | 1.52 |
YES | 17.7 | 18.4 | (0.72–1.54) | |
Arrhythmia | NO | 85.7 | 78.6 | 1.64 |
YES | 14.3 | 21.4 | (1.15–2.34) | |
Diabetes | NO | 66.1 | 69.9 | 0.83 |
YES | 33.9 | 30.1 | (0.61–1.15) | |
CerebroVascular Disease | NO | 85.4 | 84.2 | 1.19 |
YES | 14.6 | 15.8 | (0.90–1.56) | |
Dementia | NO | 97.6 | 95.9 | 1.75 |
YES | 2.4 | 4.1 | (0.82–3.70) | |
Liver disease | NO | 95.1 | 94.9 | 1.05 |
YES | 4.9 | 5.1 | (0.54–2.03) | |
Left ventricular Hypertrophy | NO | 48.8 | 57.1 | 0.72 |
YES | 51.2 | 42.9 | (0.54–0.96) | |
Cancer | NO | 85.1 | 76.0 | 1.80 |
YES | 14.9 | 24.0 | (1.27–2.55) | |
Nutritional status | Normal | 83.3 | 53.1 | 3.06 |
Malnutrition | 14.2 | 34.7 | (2.46–3.85) | |
Severe malnutrition | 2.5 | 12.2 | ||
Albumin (g/L) | <25 | 10.0 | 24.0 | 1.67 |
25–30 | 12.1 | 27.0 | (1.48–1.87) | |
30–35 | 24.3 | 21.9 | ||
35–40 | 35.7 | 19.9 | ||
≥40 | 17.9 | 7.1 | ||
C-reactive protein (mg/L) | <15 | 65.6 | 27.6 | 2.76 |
15–60 | 24.0 | 39.3 | (2.29–3.31) | |
≥60 | 10.4 | 33.2 | ||
Renal Replacement Therapy | Hospital HD | 78.9 | 87.0 | 1.78 |
Satellite HD | 9.2 | 6.2 | (1.54–2.1) | |
PD | 11.3 | 6.9 | ||